EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS · Delayed Price · Currency is USD
369.90
+1.79 (0.49%)
Oct 31, 2025, 4:00 PM EDT
ESLOF Market Cap
ESLOF has a market cap or net worth of $168.77 billion as of October 31, 2025. Its market cap has increased by 55.90% in one year.
Market Cap
168.77B
Enterprise Value
182.43B
Revenue
31.99B
Ranking
n/a
PE Ratio
60.36
Stock Price
$369.90
Market Cap Chart
Since February 11, 1992, ESLOF's market cap has increased from 474.08M to 168.77B, an increase of 35,499.63%. That is a compound annual growth rate of 19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 168.77B | 51.82% |
| Dec 31, 2024 | 111.17B | 22.76% |
| Dec 29, 2023 | 90.56B | 14.56% |
| Dec 30, 2022 | 79.05B | -15.86% |
| Dec 31, 2021 | 93.95B | 38.01% |
| Dec 31, 2020 | 68.07B | 3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 569.74M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 305.06M |
| CytoDyn | 302.34M |